Study guide

14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function

IJCAHPO Certified Ophthalmic Medical Technologist COMT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements

1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification

2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology

2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway

3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety

3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety

4 Chapter 4: Ophthalmic History Taking & Clinical Documentation

4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record

5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision

5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction

6 Chapter 6: Tonometry, Keratometry & Pupil Measurement

6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria

7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis

7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment

8 Chapter 8: Refraction, Retinoscopy & Refinement

8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations

9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics

9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations

10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy

10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training

11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation

11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing

12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique

12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics

13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols

13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials

14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)

14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics

15 Chapter 15: Fluorescein Angiography Principles & Technique

15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management

16 Chapter 16: Angiographic Interpretation & Pathology

16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology

17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography

17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers

18 Chapter 18: Ophthalmic Photography & Videography

18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management

19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)

19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging

20 Chapter 20: Biometry, Topography & Corneal Analysis

20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth

21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting

21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems

22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications

22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis

23 Chapter 23: Ocular Pharmacology

23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF

24 Chapter 24: Microbiology & Ocular Specimen Collection

24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection

25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery

25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs

26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery

26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol

27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures

27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)

28 Chapter 28: Ophthalmic Patient Services & Education

28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support

29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance

29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements

14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function

Key Takeaways Explain This Topic AI

The pattern electroretinogram (PERG) is evoked by a high-contrast reversing checkerboard or grating stimulus that maintains constant mean luminance, isolating contrast-sensitive retinal elements without evoking luminance-driven mass outer retinal responses.

The transient PERG waveform comprises an early negative trough (N35), a prominent positive peak at ~50 ms (P50, reflecting macular photoreceptor and ON/OFF bipolar cell function), and a broad negative trough at ~95 ms (N95, generated directly by spiking retinal ganglion cells).

In early glaucomatous optic neuropathy and pre-perimetric glaucoma, the N95 amplitude is selectively reduced while the P50 amplitude remains preserved, yielding an abnormally reduced N95:P50 amplitude ratio.

PERG serves as the definitive electrophysiologic discriminator between macular disease (marked P50 attenuation with proportional secondary N95 loss) and optic nerve dysfunction (isolated N95 loss with normal P50).

Testing requires undilated natural pupils to preserve optical depth of field, optimal refractive correction for the exact testing distance, and non-distorting corneal electrodes (e.g., DTL fiber) because contact lens electrodes distort pattern clarity.

Last updated: September 2026

Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function

Core Clinical Mandate: Conventional flash electroretinography provides vital data regarding photoreceptors and bipolar cells but is blind to diseases of the third-order retinal neurons—the retinal ganglion cells (RGCs). The pattern electroretinogram (PERG) isolates inner retinal ganglion cell activity and central macular function by stimulating the retina with a high-contrast patterned stimulus that reverses at a constant mean luminance.

Biophysical Principles: The Constant Mean Luminance Paradigm

To record electrical activity arising specifically from contrast-sensitive retinal circuits rather than diffuse luminance changes, PERG employs a specialized visual stimulus:

Elimination of Stray Light and Mass Luminance Responses

In a standard flash ERG, the flash causes a net increase in total retinal illumination, evoking a massive, diffuse electrical wave from millions of photoreceptors across the entire eye.

In Pattern ERG , the stimulus is a black-and-white checkerboard (or square-wave grating) displayed on a video monitor. When the pattern reverses, black checks become white, and white checks become black.

Constant Mean Luminance: Because the total number of white and black checks remains identical throughout each reversal phase, the overall light flux entering the eye remains strictly constant (typically standardized to 50 to 100 cd/m²).

Physiological Consequence: Because there is no change in net illumination, stray light does not illuminate or excite the peripheral retina. The electrical response is generated solely by local receptive fields undergoing contrast reversal within the central field of view (typically central 10° to 15°). Pattern Reversal Mechanism (Constant Mean Luminance):

  • State A: [⬛ ⬜ ⬛ ⬜] ──► Total Light Flux = 50 cd/m²
  • State B: [⬜ ⬛ ⬜ ⬛] ──► Total Light Flux = 50 cd/m² (Zero Net Luminance Shift)

Result: Isolates local retinal ganglion cell and macular contrast processing!

Parameter Flash Electroretinogram (ffERG) Pattern Electroretinogram (PERG)

Stimulus Mode High-intensity light flashes in Ganzfeld sphere High-contrast reversing checkerboard on video display

Mean Retinal Luminance Rapid dynamic increases (flash onset) Strictly constant throughout pattern reversal

Cellular Structures Tested Photoreceptors (rods/cones) & Bipolar/Müller cells Retinal Ganglion Cells (RGCs) & Macular Cones

  • Stray Light Stimulation Massive peripheral retinal stimulation Negligible ; localized entirely to pattern area
  • Pupillary Status Fully dilated (pharmacological mydriasis) Undilated (natural pupil) to maximize image focus
  • Optic Nerve Sensitivity Normal in total optic nerve atrophy Extinguished / abnormal N95 in optic atrophy

Loading diagram... PERG Waveform Architecture and Cellular Origin Pathway

ISCEV Standard PERG Waveforms and Neurophysiologic Generators

Under International Society for Clinical Electrophysiology of Vision (ISCEV) standards, two distinct recording paradigms are recognized: Transient PERG and Steady-State PERG .

1. Transient PERG (The Clinical Gold Standard)

When the checkerboard reverses at a slow rate ( 2 to 4 reversals per second , or 1.0 to 2.0 Hz), the retina has sufficient time to complete its full electrical response before the next reversal occurs. The resulting waveform is transient and consists of three distinct components: P50 Peak (~50 ms, Macular Cones & Bipolar Cells)

  • /\
  • / \
  • / \
  • ____/ \ Baseline (0 µV)
  • \ / \ ----------------
  • \/ \ /
  • N35 Trough \ /
  • (~35 ms) \_______/
  • N95 Trough (~95 ms, Retinal Ganglion Cells)

N35 Component:

Polarity and Timing: Small initial negative deflection occurring at approximately 35 milliseconds post-reversal.

Origin: Early inner/middle retinal response; often small or inconsistent in normal subjects.

P50 Component:

Polarity and Timing: Prominent, robust positive peak occurring at approximately 50 milliseconds (normal range: 45 to 55 ms).

Cellular Origin: Generated predominantly by the central macular cone photoreceptors and downstream depolarizing ON- and OFF-bipolar cells .

Clinical Role: Represents the functional integrity of the macular photoreceptor and middle retinal pathways. If the macula is diseased, P50 amplitude is severely attenuated.

N95 Component:

Polarity and Timing: Broad, large negative trough occurring at approximately 95 milliseconds (normal range: 90 to 105 ms).

Cellular Origin: Generated directly by Retinal Ganglion Cells (RGCs) , driven specifically by sodium-dependent spiking action potentials in RGC soma and their unmyelinated axons within the retinal nerve fiber layer (RNFL).

Clinical Role: The definitive objective electrophysiologic marker of ganglion cell viability. It is selectively destroyed in optic neuropathies and glaucoma.

2. Steady-State PERG

When the reversal rate is increased to 15 to 20 reversals per second (7.5 to 10.0 Hz), individual transient components fuse into a continuous, sinusoidal waveform:

Analysis Mode: Analyzed in the frequency domain via Fast Fourier Transform (FFT) rather than individual time-domain peak latencies.

Parameters: Yields second-harmonic amplitude (microvolts) and phase angle (degrees/milliseconds).

Clinical Use: High-throughput screening for early glaucoma; sensitive to metabolic stress in ganglion cells before structural cell loss.

Clinical Discriminator: Maculopathy vs. Optic Neuropathy

The most powerful diagnostic application of the transient PERG is its unique ability to differentiate visual loss caused by occult macular disease from that caused by optic nerve dysfunction .

The N95:P50 Ratio Principle

Because the P50 component originates in macular photoreceptors/bipolar cells, and the N95 component originates downstream in the retinal ganglion cells, comparing their relative amplitudes identifies the precise anatomical site of visual pathology: PERG Ratio = Amplitude of N95 (measured from P50 peak to N95 trough) Amplitude of P50 (measured from baseline or N35 to P50 peak) \text{PERG Ratio} = \frac{\text{Amplitude of N95 (measured from P50 peak to N95 trough)}}{\text{Amplitude of P50 (measured from baseline or N35 to P50 peak)}} PERG Ratio = Amplitude of P50 (measured from baseline or N35 to P50 peak) Amplitude of N95 (measured from P50 peak to N95 trough) ​

In a healthy adult eye, the N95 amplitude is substantially larger than the P50 amplitude, yielding an N95:P50 ratio typically between 1.1 and 1.5 .

1. Primary Optic Nerve Disease (Glaucoma, Optic Neuritis, Ischemic Optic Neuropathy)

Electrophysiologic Finding: Isolated loss or marked attenuation of N95 , with complete preservation of P50 (normal amplitude and implicit time).

Pathophysiology: Ganglion cells are damaged, extinguishing the N95 wave. However, the upstream macular photoreceptors and bipolar cells remain completely intact, generating a robust P50 peak.

Diagnostic Ratio: Abnormally low N95:P50 ratio (<1.0, frequently <0.8).

2. Primary Macular Disease (Macular Degeneration, Stargardt, Macular Edema)

Electrophysiologic Finding: Marked reduction or extinction of P50 .

Pathophysiology: Because the ganglion cells rely on upstream excitatory synaptic drive from macular photoreceptors and bipolar cells, damage to the macula prevents generation of the P50 wave. Furthermore, because input to the ganglion cells is cut off, the downstream N95 wave is secondarily reduced in direct proportion to P50 loss.

Diagnostic Ratio: The N95:P50 ratio remains relatively normal (~1.1–1.3), even though absolute voltages of both peaks are severely depressed.

Diagnostic Category P50 Amplitude / Latency N95 Amplitude N95:P50 Ratio Typical Clinical Entities

Normal Healthy Eye Normal (~2.5–5.0 µV, ~50 ms) Normal (~4.0–8.0 µV) Normal (1.1 to 1.5) Normal visual function

Primary Optic Neuropathy Normal (intact macula) Markedly Reduced Severely Reduced (<0.8) Glaucoma, Optic Neuritis, NAION, Leber hereditary optic neuropathy

Primary Maculopathy Markedly Reduced / Delayed Secondarily Reduced Preserved / Normal ARMD, Stargardt, Cone dystrophy, Macular hole, CSCR

Non-Organic Visual Loss Completely Normal Completely Normal Normal Malingering, Conversion disorder (proves organic visual system intact)

Glaucomatous Neurodegeneration and Pre-Perimetric RGC Stress

Glaucoma is characterized by the progressive, apoptotic death of retinal ganglion cells and axonal thinning in the retinal nerve fiber layer (RNFL). A critical clinical challenge is identifying glaucomatous damage before irreversible visual field loss occurs.

Pre-Perimetric Ganglion Cell Dysfunction

The Latent Structural-Functional Gap: On standard automated perimetry (e.g., Humphrey 24-2), up to 30% to 50% of retinal ganglion cells can be lost before a reproducible, statistically significant visual field scotoma appears.

Reversible Metabolic Stress: Prior to undergoing apoptosis, retinal ganglion cells enter a prolonged state of sublethal metabolic dysfunction and axonal transport failure.

PERG Biomarker: PERG detects this early functional compromise. In ocular hypertension and "glaucoma suspect" eyes, a significant reduction in N95 amplitude (or steady-state PERG amplitude attenuation and phase delay) indicates active RGC dysfunction.

Reversibility Upon Pressure Lowering: Clinical trials have demonstrated that when intraocular pressure (IOP) is pharmacologically or surgically lowered in ocular hypertensive eyes with abnormal PERG signals, the N95 amplitude can partially or completely normalize . This confirms that PERG detects sick, stressed ganglion cells before permanent structural death, establishing it as a vital tool for early therapeutic intervention.

Clinical Role in Non-Organic Visual Loss (Malingering)

Patients feigning severe visual acuity loss or total blindness present a diagnostic dilemma in forensic and disability examinations:

If a malingering patient claims counting-fingers vision or complete blindness, a completely normal transient PERG (normal P50 and N95 amplitudes and waveforms) objectively proves that the central macula, foveal photoreceptors, and retinal ganglion cells are structurally and electrophysiologically intact .

Because PERG requires clear retinal imaging and attention, a normal response confirms that the patient is fixating and focusing on the target, ruling out anterior organic pathology.

Technologist Protocol, Patient Preparation, and Technical Execution

Because PERG voltages are minuscule (typically 2 to 8 microvolts, roughly one-fiftieth the amplitude of a full-field ERG b-wave), technical precision and artifact control are paramount.

1. Pupillary Status: The Strict Non-Mydriasis Rule

Never Dilate the Patient for PERG: The patient's pupils must remain naturally undilated .

Optical Mechanism: Pharmacological dilation (mydriasis) paralyses accommodation, induces massive spherical and chromatic optical aberrations, and dramatically reduces optical depth of field. This blurs the sharp borders of the checkerboard pattern on the macula, causing severe, artificial dampening of both P50 and N95 amplitudes.

Technologist Workflow Rule: If a patient is scheduled for both PERG and full-field ERG / mfERG on the same day, PERG must always be performed FIRST , while pupils are natural. Dilation drops are instilled only after PERG recording is completed.

2. Precise Refractive Correction for Working Distance

The patient must be refracted for the exact testing distance (typically 1.0 meter for PERG).

Uncorrected spherical or cylindrical error as small as 1.00 diopter can reduce P50 and N95 amplitudes by up to 50%.

Technologists must place wide-aperture trial lenses directly in front of the tested eye, ensuring the lens optical center is perfectly aligned with the visual axis to avoid prismatic displacement or rim-induced field occlusion.

3. Corneal Electrode Selection and Placement

To preserve clear, undistorted retinal image formation, rigid contact lens electrodes are contraindicated in PERG:

DTL (Dawson-Trick-Litzkow) Fiber Electrode: The preferred electrode. Placed into the inferior conjunctival fornix with its conductive silver filament resting gently across the lower lid margin and bulbar conjunctiva. It produces no optical degradation, corneal indentation, or tear film disruption.

Gold Foil Electrode: Hooked over the lower lid margin, providing high signal-to-noise ratio without contacting the optical cornea.

Reference Electrodes: Placed at the ipsilateral outer canthus.

Ground Electrode: Placed on the central forehead (Fpz) or earlobe.

Impedance Matching: Ensure all skin electrode impedances are balanced and below 5 kΩ .

4. Monocular vs. Binocular Testing and Fixation Maintenance

Testing is typically performed monocularly with the contralateral eye securely patched, though binocular testing is permitted under ISCEV guidelines if binocular fixation is stable.

Instruct the patient to fixate steadily on a small red fixation cross centered in the checkerboard.

Excessive blinking or saccades introduce large baseline shifts and muscular artifacts; computerized artifact rejection gates discard contaminated sweeps.